Module 14. Myocardial Viability with PET Clinical Data-Myocardial Viability with PET Clinical Data (Presentation)

Video Transcription

Video Summary

In this video, Dr. Wael Jaber from the Cleveland Clinic discusses non-perfusion PET imaging and its role in assessing myocardial viability and hibernation. He explains the concepts of ischemia, viability, hibernation, and scar, and the role of PET-FTG imaging in assessing myocardial viability. He discusses how PET-FTG data is used in diagnosing viable myocardium or hibernating myocardium in clinical practice. He also goes over the American Society of Nuclear Cardiology's practice points for patient preparation and image acquisition, and provides a critical assessment of what components should be in the interpretation report for referring physicians. Dr. Jaber emphasizes the importance of selecting the right patients for viability assessment and the limitations of past literature on the topic. He highlights findings from the STITCH and PART 2 trials, which support the clinical benefits of viability assessment and PET-guided therapy. Dr. Jaber also discusses the strategies for interpreting and reporting viability scans, and emphasizes the need for clear communication of the results to referring physicians. The video aims to provide an overview of non-perfusion PET imaging and its role in clinical practice.

Keywords

non-perfusion PET imaging

myocardial viability

hibernation

ischemia

scar

PET-FTG imaging

American Society of Nuclear Cardiology

viability assessment